세계의 심장 판막 기기 시장 : 제품 유형별, 시술별, 최종 용도별 예측(2024-2032년)

Heart Valve Devices Market size is expected to garner more than 8.6% CAGR from 2024-2032, driven by growing aging population, technological advancements in heart valve devices, and the rising demand for minimally invasive procedures.

With cardiovascular diseases emerging as a leading cause of mortality worldwide, there is a pressing need for effective treatment options to address this growing health concern. According to American College of Cardiology, global deaths attributed to cardiovascular diseases (CVD) surged from 12.4 million in 1990 to 19.8 million in 2022. Factors, such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, and the aging population are contributing to the escalating burden of cardiovascular diseases globally.

As the incidence of conditions like heart valve disorders, coronary artery disease, and heart failure continues to rise, the demand for advanced medical interventions, including heart valve devices, is expected to increase substantially. This trend is evident in both developed and developing countries, where healthcare systems are striving to meet the growing needs of patients with cardiovascular ailments. Consequently, the expanding patient pool and the rising demand for treatment options are compelling manufacturers to focus on developing innovative solutions to address the evolving healthcare landscape.

The heart valve devices market is classified based on product type, procedure, end-use and region.

By product type, the industry size from the transcatheter heart valves product segment is expected to grow at 8.9% CAGR from 2024 to 2032. These valves offer a less invasive alternative to traditional open-heart surgeries, enabling patients to undergo valve replacement procedures with reduced post-operative complications and shorter recovery times. This innovative approach has also garnered widespread acceptance among both patients and healthcare providers, driving the segment growth.

Heart valve devices industry from the repair procedures segment will expand significantly at 8.7% growth rate through 2032. Repair procedures offer several advantages over valve replacement, including better preservation of cardiac anatomy and function, reduced risk of long-term complications, and improved patient quality of life. As a result, there is growing interest in the development and adoption of repair techniques for the management of valvular heart diseases.

Asia Pacific heart valve devices industry size is set to record 9.8% CAGR between 2024 and 2032, driven by the rising prevalence of cardiovascular diseases, improving healthcare infrastructure, and increasing healthcare expenditure. Countries, such as China, India, and Japan are witnessing a surge in demand for cardiac interventions, driven by demographic changes, lifestyle factors, and increasing awareness about cardiovascular health. Moreover, government initiatives aimed at expanding access to healthcare services and promoting medical tourism are further contributing to market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Government initiatives and funding support
    • 3.2.1.4 Rising preference for minimally invasive procedures
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory approval processes
    • 3.2.2.2 Potential complications and adverse events
• 3.3 Growth potential analysis
• 3.4 Porter's analysis
  • 3.4.1 Supplier power
  • 3.4.2 Buyer power
  • 3.4.3 Threat of new entrants
  • 3.4.4 Threat of substitutes
  • 3.4.5 Industry rivalry
• 3.5 PESTEL analysis
• 3.6 Pricing analysis, 2023
• 3.7 Reimbursement scenario
• 3.8 Regulatory landscape
• 3.9 Technological landscape
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Mechanical heart valves
  • 5.2.1 Aortic valve
  • 5.2.2 Mital valve
• 5.3 Transcatheter heart valves
  • 5.3.1 Aortic valve
  • 5.3.2 Mital valve
  • 5.3.3 Pulmonary valve
  • 5.3.4 Tricuspid valve
• 5.4 Biological heart valves
  • 5.4.1 Aortic valve
  • 5.4.2 Mital valve

Chapter 6 Market Estimates and Forecast, By Procedure, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Replacement procedures
  • 6.2.1 Surgical aortic valve replacement (SAVR)
  • 6.2.2 Transcatheter aortic valve replacement (TAVR)
  • 6.2.3 Transcatheter mitral valve replacement (TMVR)
  • 6.2.4 Other replacement procedures
• 6.3 Repair procedures
  • 6.3.1 Transcatheter mitral valve repair (TMVr)
  • 6.3.2 Transcatheter tricuspid valve repair (TTVr)
  • 6.3.3 Valvuloplasty
  • 6.3.4 Other repair procedures

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Cardiac catheterization labs
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Artivion, Inc
• 9.3 Boston Scientific Corporation
• 9.4 Colibri Heart Valve
• 9.5 Edwards Lifesciences Corporation
• 9.6 JenaValve
• 9.7 LivaNova PLC
• 9.8 Medtronic plc
• 9.9 Symetis
• 9.10 TTK Healthcare Limited